Literature DB >> 25123268

miR-203a regulates proliferation, migration, and apoptosis by targeting glycogen synthase kinase-3β in human renal cell carcinoma.

Guanghui Hu1, Peng Lai, Min Liu, Liang Xu, Zhuifeng Guo, Huan Liu, Wei Li, Gangchun Wang, Xudong Yao, Junhua Zheng, Yunfei Xu.   

Abstract

MicroRNAs play a crucial role in cancer progression and metastasis. miR-203a has been identified as a tumor suppressor in various cancers. However, its functions in renal cell carcinoma have not been illustrated. In this study, we detected the miR-203a expression in renal cell carcinoma and evaluated its association with clinical features. Overexpression of miR-203a was found in renal cell carcinoma tissues and renal cell carcinoma cells. High miR-203a expression is correlated with tumor stage and short overall survival time. Bioinformatics and luciferase assay confirmed that glycogen synthase kinase-3β was a target gene of miR-203a. Silencing of miR-203a could inhibit cell proliferation and migration, arrest them in G1 phase, and promote apoptosis in vitro. miR-203a promotes the progression of renal cell carcinoma and predicts a poor prognosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25123268     DOI: 10.1007/s13277-014-2476-x

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  33 in total

Review 1.  The renaissance of GSK3.

Authors:  P Cohen; S Frame
Journal:  Nat Rev Mol Cell Biol       Date:  2001-10       Impact factor: 94.444

Review 2.  Renal-cell carcinoma.

Authors:  Herbert T Cohen; Francis J McGovern
Journal:  N Engl J Med       Date:  2005-12-08       Impact factor: 91.245

3.  miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression.

Authors:  Jian Li; Yuxiang Chen; Jingfeng Zhao; Fangren Kong; Yangde Zhang
Journal:  Cancer Lett       Date:  2011-02-26       Impact factor: 8.679

4.  GSK3β controls epithelial-mesenchymal transition and tumor metastasis by CHIP-mediated degradation of Slug.

Authors:  S-H Kao; W-L Wang; C-Y Chen; Y-L Chang; Y-Y Wu; Y-T Wang; S-P Wang; A I Nesvizhskii; Y-J Chen; T-M Hong; P-C Yang
Journal:  Oncogene       Date:  2013-07-15       Impact factor: 9.867

Review 5.  MicroRNA control of signal transduction.

Authors:  Masafumi Inui; Graziano Martello; Stefano Piccolo
Journal:  Nat Rev Mol Cell Biol       Date:  2010-03-10       Impact factor: 94.444

6.  MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells.

Authors:  Chen Wang; Xiangqian Zheng; Chunyan Shen; Yurong Shi
Journal:  J Exp Clin Cancer Res       Date:  2012-06-19

7.  Glycogen synthase kinase 3 beta inhibits microRNA-183-96-182 cluster via the β-Catenin/TCF/LEF-1 pathway in gastric cancer cells.

Authors:  Xiaoli Tang; Dong Zheng; Ping Hu; Zongyue Zeng; Ming Li; Lynne Tucker; Renee Monahan; Murray B Resnick; Manran Liu; Bharat Ramratnam
Journal:  Nucleic Acids Res       Date:  2013-12-13       Impact factor: 16.971

8.  MiR203 mediates subversion of stem cell properties during mammary epithelial differentiation via repression of ΔNP63α and promotes mesenchymal-to-epithelial transition.

Authors:  A J DeCastro; K A Dunphy; J Hutchinson; A L Balboni; P Cherukuri; D J Jerry; J DiRenzo
Journal:  Cell Death Dis       Date:  2013-02-28       Impact factor: 8.469

9.  miR-203 inhibits cell proliferation and migration of lung cancer cells by targeting PKCα.

Authors:  Chen Wang; Xueliang Wang; Hongwei Liang; Tao Wang; Xin Yan; Minghui Cao; Nan Wang; Suyang Zhang; Ke Zen; Chenyu Zhang; Xi Chen
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

10.  Glycogen synthase kinase 3 promotes p53 mRNA translation via phosphorylation of RNPC1.

Authors:  Min Zhang; Jin Zhang; Xiangling Chen; Seong-Jun Cho; Xinbin Chen
Journal:  Genes Dev       Date:  2013-10-15       Impact factor: 11.361

View more
  14 in total

1.  miR-106a* inhibits the proliferation of renal carcinoma cells by targeting IRS-2.

Authors:  Yadong Ma; Hongyi Zhang; Xiaolong He; Hongxiong Song; Yayong Qiang; Yi Li; Jixue Gao; Ziming Wang
Journal:  Tumour Biol       Date:  2015-05-28

2.  Linc01133 promotes proliferation and metastasis of human renal cell carcinoma through sponging miR-760.

Authors:  Wei Lv; Yan Li; Liye Fu; Fandong Meng; Jun Li
Journal:  Cell Cycle       Date:  2022-04-21       Impact factor: 5.173

3.  miR-203a suppresses cell proliferation by targeting E2F transcription factor 3 in human gastric cancer.

Authors:  Huiqin Yang; Lixia Wang; Xiaoli Tang; Wenmei Bai
Journal:  Oncol Lett       Date:  2017-10-17       Impact factor: 2.967

4.  EGR1 mediates miR-203a suppress the hepatocellular carcinoma cells progression by targeting HOXD3 through EGFR signaling pathway.

Authors:  Lumin Wang; Hongfei Sun; Xiaofei Wang; Ni Hou; Lingyu Zhao; Dongdong Tong; Kang He; Yang Yang; Tusheng Song; Jun Yang; Chen Huang
Journal:  Oncotarget       Date:  2016-07-19

5.  HOXD3 targeted by miR-203a suppresses cell metastasis and angiogenesis through VEGFR in human hepatocellular carcinoma cells.

Authors:  Lumin Wang; Dongdong Tong; Qingqing Guo; Xiaofei Wang; Fei Wu; Qian Li; Juan Yang; Lingyu Zhao; Yannan Qin; Yingxun Liu; Chen Huang
Journal:  Sci Rep       Date:  2018-02-05       Impact factor: 4.379

6.  Identification of novel genetic regulations associated with airway epithelial homeostasis using next-generation sequencing data and bioinformatics approaches.

Authors:  Chau-Chyun Sheu; Ming-Ju Tsai; Feng-Wei Chen; Kuo-Feng Chang; Wei-An Chang; Inn-Wen Chong; Po-Lin Kuo; Ya-Ling Hsu
Journal:  Oncotarget       Date:  2017-07-31

7.  MiR-99b-5p and miR-203a-3p Function as Tumor Suppressors by Targeting IGF-1R in Gastric Cancer.

Authors:  Zhenzhen Wang; Zhenghao Zhao; Yang Yang; Mai Luo; Min Zhang; Xiaofei Wang; Liying Liu; Ni Hou; Qingqing Guo; Tusheng Song; Bo Guo; Chen Huang
Journal:  Sci Rep       Date:  2018-07-04       Impact factor: 4.379

8.  Nrdp1-mediated degradation of BRUCE decreases cell viability and induces apoptosis in human 786-O renal cell carcinoma cells.

Authors:  Shao-Jun Chen; Jian-Hai Lin; Xu-Dong Yao; Bo Peng; Yun-Fei Xu; Min Liu; Jun-Hua Zheng
Journal:  Exp Ther Med       Date:  2016-05-18       Impact factor: 2.447

9.  miR-203a-3p.1 is involved in the regulation of osteogenic differentiation by directly targeting Smad9 in MM-MSCs.

Authors:  Fang-Yi Fan; Rui Deng; Ling Qiu; Qin Wen; Yunjing Zeng; Li Gao; Chen Zhang; Peiyan Kong; Jiangfan Zhong; Ningyu Zeng; Zhengyu Li; Yi Su; Xi Zhang
Journal:  Oncol Lett       Date:  2019-10-17       Impact factor: 2.967

10.  miR-124 and miR-203 synergistically inactivate EMT pathway via coregulation of ZEB2 in clear cell renal cell carcinoma (ccRCC).

Authors:  Jiajia Chen; Yuqing Zhong; Liangzhi Li
Journal:  J Transl Med       Date:  2020-02-11       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.